Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -158.1% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 0.5 | n/a |
Pr/Book | n/a |
Latest | F'cast | |
---|---|---|
Revenue | -18.7% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-20 | 8.28 | (4.70) | (2.69)p | n/a | n/a | n/a | n/a | 0.0% |
31-Mar-21 | 5.68 | (8.08) | (4.45)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-22 | 11.11 | (8.32) | (2.77)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-23 | 2.98 | (14.12) | (5.49)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-24 | 2.42 | (4.30) | (0.33)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Audited Results for year ended 30 September 2024 | 27-Mar-2025 | 07:00 | RNS |
Result of General Meeting | 24-Mar-2025 | 11:24 | RNS |
Notice of General Meeting | 05-Mar-2025 | 07:00 | RNS |
Versarien subsidiary awarded EUR 0.8m grant | 13-Dec-2024 | ShareCast |
Versarien upbeat on recent company progress | 04-Oct-2024 | ShareCast |
Versarien sells AAC Cyroma subsidiary for £0.55m | 30-Sep-2024 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 0.029p |
Change Today | 0.001p |
% Change | 1.75 % |
52 Week High | 0.13 |
52 Week Low | 0.026 |
Volume | 13,803,399 |
Shares Issued | 4,464.51m |
Market Cap | £1.29m |
Beta | 0.05 |
RiskGrade | 561 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
16:30 | 23,053 @ 0.032p |
16:30 | 5,000 @ 0.032p |
16:30 | 2,611 @ 0.032p |
16:15 | 312,500 @ 0.026p |
16:15 | 94,309 @ 0.026p |
Finance Director | Christopher Leigh |
CEO | Stephen Hodge |
You are here: research